Patrick Stoy

916 total citations
19 papers, 615 citations indexed

About

Patrick Stoy is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Patrick Stoy has authored 19 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Patrick Stoy's work include Asymmetric Synthesis and Catalysis (4 papers), Chemical Synthesis and Analysis (3 papers) and Advanced Synthetic Organic Chemistry (3 papers). Patrick Stoy is often cited by papers focused on Asymmetric Synthesis and Catalysis (4 papers), Chemical Synthesis and Analysis (3 papers) and Advanced Synthetic Organic Chemistry (3 papers). Patrick Stoy collaborates with scholars based in United States, Germany and United Kingdom. Patrick Stoy's co-authors include William H. Pearson, Yuan Mi, Andrew Jordan, Helen F. Sneddon, Ill Young Lee, David A. Berry, Anthony D. Sercel, Brian G. Lawhorn, Andrew J. Watson and Bin He and has published in prestigious journals such as Chemical Reviews, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Patrick Stoy

19 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Stoy United States 12 369 213 45 36 36 19 615
Simona Sputore Italy 5 755 2.0× 288 1.4× 59 1.3× 23 0.6× 104 2.9× 6 956
Daniel Bauer Switzerland 13 152 0.4× 191 0.9× 78 1.7× 15 0.4× 17 0.5× 34 561
Sung Hwan Kim South Korea 21 776 2.1× 326 1.5× 40 0.9× 3 0.1× 37 1.0× 46 1.1k
Ruka Nakashima Japan 15 215 0.6× 237 1.1× 38 0.8× 6 0.2× 79 2.2× 56 745
Takehiko Yoshimitsu Japan 21 1.0k 2.8× 266 1.2× 74 1.6× 37 1.0× 142 3.9× 63 1.3k
Darko Kantoci United States 18 342 0.9× 304 1.4× 40 0.9× 10 0.3× 174 4.8× 38 905
Lamont R. Terrell United States 7 419 1.1× 133 0.6× 9 0.2× 30 0.8× 27 0.8× 9 474
Piero Melloni Italy 16 247 0.7× 429 2.0× 24 0.5× 4 0.1× 58 1.6× 43 725
John Bruno United States 17 274 0.7× 253 1.2× 22 0.5× 11 0.3× 94 2.6× 27 658
Lou Jian-shi China 12 223 0.6× 149 0.7× 54 1.2× 5 0.1× 31 0.9× 38 597

Countries citing papers authored by Patrick Stoy

Since Specialization
Citations

This map shows the geographic impact of Patrick Stoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Stoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Stoy more than expected).

Fields of papers citing papers by Patrick Stoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Stoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Stoy. The network helps show where Patrick Stoy may publish in the future.

Co-authorship network of co-authors of Patrick Stoy

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Stoy. A scholar is included among the top collaborators of Patrick Stoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Stoy. Patrick Stoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Soefje, Scott A., Ediz S. Calay, Yi Lin, et al.. (2023). Real-World Treatment Outcomes of Teclistamab Under an Outpatient Model for Step-up Dosing Administration. Blood. 142(Supplement 1). 5154–5154. 6 indexed citations
2.
Patterson, Jaclyn R., Alan P. Graves, Patrick Stoy, et al.. (2021). Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf. Journal of Medicinal Chemistry. 64(21). 15651–15670. 4 indexed citations
3.
Xu, Xiaoping, Navin Goyal, Melissa H. Costell, et al.. (2020). Identification of a Human Whole Blood–Based Endothelial Cell Impedance Assay for Assessing Clinical Transient Receptor Potential Vanilloid 4 Target Engagement Ex Vivo. Journal of Pharmacology and Experimental Therapeutics. 376(3). 436–443. 1 indexed citations
4.
Patterson, Jaclyn R., Lamont R. Terrell, Carla A. Donatelli, et al.. (2020). Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions. Journal of Medicinal Chemistry. 63(23). 14867–14884. 10 indexed citations
5.
Jordan, Andrew, Patrick Stoy, & Helen F. Sneddon. (2020). Chlorinated Solvents: Their Advantages, Disadvantages, and Alternatives in Organic and Medicinal Chemistry. Chemical Reviews. 121(3). 1582–1622. 105 indexed citations
6.
Behm, David J., Hilary S. Eidam, Marlys Hammond, et al.. (2019). Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4). ACS Medicinal Chemistry Letters. 10(8). 1228–1233. 36 indexed citations
7.
Stoy, Patrick, et al.. (2018). Advances in Lead Generation. Bioorganic & Medicinal Chemistry Letters. 29(4). 517–524. 19 indexed citations
8.
Brnardic, Edward J., Guosen Ye, Carla A. Donatelli, et al.. (2018). Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4). Journal of Medicinal Chemistry. 61(21). 9738–9755. 20 indexed citations
9.
Vagnozzi, Ronald J., Gregory J. Gatto, Lara S. Kallander, et al.. (2013). Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic Heart. Science Translational Medicine. 5(207). 207ra141–207ra141. 50 indexed citations
10.
Pearson, William H., et al.. (2005). Fluorous Affinity Purification of Oligonucleotides. The Journal of Organic Chemistry. 70(18). 7114–7122. 62 indexed citations
11.
Pearson, William H., Ill Young Lee, Yuan Mi, & Patrick Stoy. (2005). Total Synthesis of the Kopsia lapidilecta Alkaloid (.+‐.)‐Lapidilectine B (I).. ChemInform. 36(23). 3 indexed citations
12.
Bi, Yingzhi, Patrick Stoy, Leonard P. Adam, et al.. (2004). Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction. Bioorganic & Medicinal Chemistry Letters. 14(6). 1577–1580. 43 indexed citations
13.
Pearson, William H., et al.. (2004). Azomethine Ylides from Tin-Substituted Cyclic Carbinol Amides:  A New Route to Highly Substituted Pyrrolizidines. Organic Letters. 6(6). 1005–1008. 17 indexed citations
14.
Pearson, William H., Ill Young Lee, Yuan Mi, & Patrick Stoy. (2004). Total Synthesis of the Kopsia lapidilecta Alkaloid (±)-Lapidilectine B. The Journal of Organic Chemistry. 69(26). 9109–9122. 99 indexed citations
15.
Pearson, William H., Patrick Stoy, & Yuan Mi. (2004). A Three-Component, One-Pot Synthesis of Indolizidines and Related Heterocycles via the [3+2] Cycloaddition of Nonstabilized Azomethine Ylides. The Journal of Organic Chemistry. 69(6). 1919–1939. 42 indexed citations
16.
Stoy, Patrick, et al.. (2004). The Synthesis of 9,10‐Dihydro‐9,10‐(Methaniminomethano)Anthracene andN‐Protected Derivatives Via Double Reductive Amination. Synthetic Communications. 34(19). 3481–3489. 2 indexed citations
17.
18.
19.
Bi, Yingzhi, Patrick Stoy, Leonard P. Adam, et al.. (2001). The discovery of novel, potent and selective PDE5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(18). 2461–2464. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Sputore Breakdown of academic impact, for papers by Daniel Bauer Breakdown of academic impact, for papers by Sung Hwan Kim Breakdown of academic impact, for papers by Ruka Nakashima Breakdown of academic impact, for papers by Takehiko Yoshimitsu Breakdown of academic impact, for papers by Darko Kantoci Breakdown of academic impact, for papers by Lamont R. Terrell Breakdown of academic impact, for papers by Piero Melloni Breakdown of academic impact, for papers by John Bruno Breakdown of academic impact, for papers by Lou Jian-shi
Rankless by CCL
2026